Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group

Treatment Patterns ◽

Pleural Mesothelioma ◽

A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7021 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7021-7021 ◽

Cited By ~ 12

Author(s):

J. P. Van Meerbeeck ◽

C. Manegold ◽

R. Gaafar ◽

R. J. van Klaveren ◽

E. A. Van Marck ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Cancer Group ◽

Phase Iii Study

A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7021 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7021-7021 ◽

Cited By ~ 1

Author(s):

J. P. Van Meerbeeck ◽

C. Manegold ◽

R. Gaafar ◽

R. J. van Klaveren ◽

E. A. Van Marck ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Cancer Group ◽

Phase Iii Study

Does disease control rate (DCR) at 9 and 18 weeks predict overall survival (OS) in patients with malignant pleural mesothelioma (MPM)? An individual patient data combined analysis of 10 European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group (LCG) studies.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7025 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7025-7025

Author(s):

L. Greillier ◽

B. Hasan ◽

P. Baas ◽

J. J. Welch ◽

J. P. Van Meerbeeck ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Disease Control ◽

Individual Patient Data ◽

Disease Control Rate ◽

Pleural Mesothelioma ◽

Combined Analysis ◽

European Organisation ◽

P-396 Treatment of malignant pleural mesothelioma with platinum-pemetrexed chemotherapy: The Leuven Lung Cancer Group experience

Lung Cancer ◽

10.1016/s0169-5002(05)80889-x ◽

2005 ◽

Vol 49 ◽

pp. S219

Author(s):

C. Dooms ◽

K. Nackaerts ◽

J. Vansteenkiste ◽

P. Nafteux ◽

H. Schmitt

Keyword(s):

Lung Cancer ◽

Pleural Mesothelioma ◽

Cancer Group ◽

Group Experience

3074 Platinum-pemetrexed palliative chemotherapy in malignant pleural mesothelioma from Spanish BEMME database The Spanish Lung Cancer Group (SLCG)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31715-4 ◽

2015 ◽

Vol 51 ◽

pp. S622

Author(s):

J. Remon ◽

N. Reguart ◽

Y. Garcia ◽

E. Nadal ◽

R. Lopez-castro ◽

...

Keyword(s):

Lung Cancer ◽

Palliative Chemotherapy ◽

Pleural Mesothelioma ◽

Progression free survival rate at 9 and 18weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation

European Journal of Cancer ◽

10.1016/j.ejca.2014.07.020 ◽

2014 ◽

Vol 50 (16) ◽

pp. 2771-2782 ◽

Cited By ~ 6

Author(s):

Baktiar Hasan ◽

Laurent Greillier ◽

Athanasios Pallis ◽

Jessica Menis ◽

Rabab Gaafar ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Survival Rate ◽

Progression Free Survival ◽

Pooled Analysis ◽

Independent Study ◽

Pleural Mesothelioma ◽

Free Survival ◽

Is ?7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Current Drug Targets ◽

10.2174/138945012800398900 ◽

2012 ◽

Vol 13 (5) ◽

pp. 688-694 ◽

Cited By ~ 18

Keyword(s):

Lung Cancer ◽

Pleural Mesothelioma

Comments on ‘High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients’

European Journal of Cancer ◽

10.1016/j.ejca.2021.03.055 ◽

2021 ◽

Author(s):

Akio Hara ◽

Masanori Matsuda ◽

Arata Ishii ◽

Takashi Yoshioka

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

High Intensity ◽

Small Cell ◽

Clinical Activity ◽

Pleural Mesothelioma ◽

Small Cell Lung ◽

Lung Cancer Patients

Immunotherapy for Lung Cancer and Malignant Pleural Mesothelioma

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0057 ◽

2021 ◽

Author(s):

Paola Ghanem ◽

Julie R Brahmer

Keyword(s):

Lung Cancer ◽

Pleural Mesothelioma

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.04.029 ◽

2019 ◽

Vol 14 (8) ◽

pp. 1343-1353 ◽

Cited By ~ 12

Author(s):

Joseph S. Friedberg ◽

Melissa J. Culligan ◽

Anne S. Tsao ◽

Valerie Rusch ◽

Boris Sepesi ◽

...

Keyword(s):

Lung Cancer ◽

National Cancer Institute ◽

Applied Research ◽

International Association ◽

Pleural Mesothelioma